February 27, 2024
Takashi Yasukawa, Pharmaceutical Management Director, Medical Economics Division, Health Insurance Bureau, MHLW The pharmaceutical industry should present tangible progress in their development activities as a result of pro-innovation reforms in FY2024 before requesting further changes in FY2026, a health ministry...read more